HIGHFDA DEVICE

Ortho-Clinical Diagnostics LAC Slides Recalled Over Calibration Failures on VITROS Systems

VITROS Chemistry Products LAC Slides recalled after calibration failures on VITROS XT 3400 and VITROS XT 7600 systems. The recall covers catalog 8433880 with 2,908 units distributed nationwide in the US. Manufacturers warn that coating 0130 and above with Condition Code TH4-63J elevates calibration failures, delaying lac test results and potentially impacting patient management. Health providers,病

Official notice
Ortho-Clinical DiagnosticsHealth & Personal CareMedical DevicesCatalog number 8433880UDI# 110758750004911Coating 0130 and above

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
July 29, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
July 29, 2025
Hazard Level
HIGH
Brand
Ortho-Clinical Diagnostics
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Ortho-Clinical Diagnostics
Product type
Laboratory Reagents / Slides
Model numbers
Catalog number 8433880, UDI# 110758750004911, Coating 0130 and above, Lot numbers 3533-0130-2317 to 3533-0131-6128
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    July 29, 2025

  2. Reported by FDA DEVICE

    September 24, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above with Condition Code TH4-63J during calibration, causing the delay of lac test results and potentially impact patient management. The issue was identified by QuidelOrtho through an increase in customer complaints compared to the historical baseline with average failure rate of 1% for coating 0130 in 2025 while average of failure rate for other coating was 0.06% in 2025 and average of failure rate for all coatings is 0.03% for 2024.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Ortho-Clinical Diagnostics, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

LAC Slides are used in chemistry testing on VITROS analyzers to perform lactate dehydrogenase tests; this recall concerns calibration reliability rather than direct product failure causing patient harm.

Why This Is Dangerous

Calibration failures can delay results, potentially affecting clinical decisions and patient management.

Industry Context

This recall is not described as part of a broader pattern.

Real-World Impact

Delays in lab results may affect treatment timelines and patient management; facilities should verify stock and contact the manufacturer for guidance.

Practical Guidance

How to identify if yours is affected

  1. Check catalog number 8433880
  2. Verify coating designation 0130 and above and TH4-63J code

Where to find product info

FDA recall page and Ortho-Clinical Diagnostics communications

What timeline to expect

Refunds/replacements timelines vary; follow manufacturer guidance

If the manufacturer is unresponsive

  • Escalate to hospital procurement or regulatory bodies; document communications; seek alternative supplier if needed.
  • Consider filing with CPSC or FDA if necessary.

How to prevent similar issues

  • Implement inventory checks for coating versions; verify lot-specific risk before use; maintain alternative stock
  • Stay updated with FDA recall notices and manufacturer alerts

Documentation advice

Keep recall notice, lot lists, and correspondence; document affected stock with location and quantity

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Catalog number 8433880. 1 Sales Unit = 5 cartridges of 60 slides, total 300 tests. Quantity recalled: 2,908 units. UDI: 110758750004911. Coating 0130 and above. Lot numbers 3533-0130-2317 through 3533-0131-6128. Sold/distributed nationwide in the US.

Reported Incidents

No specific injury or patient harm counts are provided in the summary. The hazard is described as calibration failure and potential impact on patient management.

Key Facts

  • Coating 0130+ linked to TH4-63J
  • Calibrations delays may affect patient management
  • US nationwide distribution

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
ELECTRICALOTHER

Product Details

Model Numbers
Catalog number 8433880
UDI# 110758750004911
Coating 0130 and above
Lot numbers 3533-0130-2317 to 3533-0131-6128
Affected States
ALL
Report Date
September 24, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more